Enyo Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Enyo Pharma's estimated annual revenue is currently $5.9M per year.
- Enyo Pharma's estimated revenue per employee is $155,000
Employee Data
- Enyo Pharma has 38 Employees.
- Enyo Pharma grew their employee count by -5% last year.
Enyo Pharma's People
| Name | Title | Email/Phone |
|---|
Enyo Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15640M | 246141 | N/A | N/A | $109.8B |
#2 | $4.9M | 41 | 14% | N/A | N/A |
What Is Enyo Pharma?
ENYO Pharma is a clinical stage biotech with an innovative approach inspired by viruses. Our biotech mimics virus strategy to modulate host cellular functions with multiple applications. We develop new drug candidates in multiple indications such as infectious diseases (e.g. HBV), metabolic diseases (e.g. NASH) and oncology. Our main candidate EYP001 is an FXR agonist about to enter phase 2 for both HBV and NASH and we expect to bring at least one new compound in clinic by end 2018. Our second candidate, EYP002, is currently in preclinical studies. Initially developed against influenza virus, it has a mitochondrial cellular target which leads ENYO Pharma to explore new indications such as oncology or metabolic diseases. The company has also received funding from the European Union's Horizon 2020 Research and Innovation Program for the MIMESIS project, which aims at exploring many indications. ENYO Pharma is currently based in Lyon, France and in Melbourne, Australia.
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.9M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Lyon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.4M | 38 | -10% | N/A |
#2 | $6M | 39 | -15% | N/A |
#3 | N/A | 39 | 63% | N/A |
#4 | $6.9M | 39 | 77% | N/A |
#5 | $6.9M | 41 | 8% | N/A |